| Literature DB >> 23507587 |
Abstract
The Guidance for Risk Management Plan(RMP)was released by the Ministry of Health, Labour and Welfare in April 2012. The RMP consists of safety specifications, pharmacovigilance plans and risk minimization action plans. In this paper, we outline post-marketing drug safety operations in PMDA and the RMP, with examples of some anticancer drugs.Entities:
Mesh：
Substances：
Year: 2013 PMID： 23507587
Source DB: PubMed Journal: Gan To Kagaku Ryoho ISSN： 0385-0684